Document is current

Article History

Received: 4 March 2025

Accepted: 5 April 2025

First Online: 8 May 2025

Declarations

:

: All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript. Anna Hillenmayer received speaker fees from Bayer and Novartis. Melih Parlak and Efstathios Vounotrpyidis received speaker fees from Bayer and Novartis. Prof. Dr. Armin Wolf received research grants and study fees from Allergan, Boehringer Ingelheim, Bayer, Alimera, Novartis, Oertli and Roche and consulting honoraria and travel fees from Alimera, Allergan, Bayer, Boehringer Ingelheim, Novartis, Oertli, Roche and Zeiss. For the remaining authors none conflict of interests or fundings were declared.

: The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the University of Ulm (441/2023). The authors confirm that the ethical guidelines of the journal were adhered to and that approval was obtained from the appropriate ethics committee. Verbal informed consent was obtained from the participants and approved by the Ethics Committee. In addition, written consent for publication of identifying information and accompanying images was obtained from the participating patient for the single case example.

: Written consent was obtained from all participants.

: The authors affirm that human research participants provided informed consent for publication of the images in Figs.  and .